trial · primary record
ABBV-706
Extensive Stage-Small Cell Lung Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 80 |
| Primary completion | 2031-08 |
| Primary endpoint | Objective Response (OR) measured by overall response rate (ORR) Based on Blinded Independent Central Review (BICR) Assessment Per Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 |
| Registry ID | NCT07895056 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:18.317Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07895056
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.